Construction of overexpression lentiviral vector and its expression in lung cancer A549 cells of AMPactivated protein kinase

doi:10.3760/cma.j.issn.1673-422X.2017.10.001

Abstract

Abstract: ObjectiveTo establish a stable lung cancer A549 cell line transfected by AMPactivated protein kinase (AMPK) expression vector, and to observe the effect of AMPK on proliferation as well as on the invasive ability of A549 cells. MethodsFulllength of AMPK gene was amplified and its target gene was digested, then inserted into the GV358 plasmid. Cotranfected 293T cells were subjected to the lentivirus equipment package. Subsequently, we collected the lentivirus supernatant to infect the A549 cells and establish a stably, overexpressed cell line A549. The mRNA and protein of AMPK were examined by realtime quantitative reverse transcriptase polymerase chain reaction (qRTPCR) and Western blotting. The proliferation and invasion abilities of A549 cells were detected by methyl thiazolyl thiazolium (MTT) and Transwell assay. ResultsGV358AMPK lentivirus vectors was successfully constructed by restrictive enzyme digestion and plasmid sequencing. There were significantly increased expressions of AMPK protein (5.87 times, P=0.002) and mRNA (16.12 times, P＜0.001) after transfected with GV358AMPK compared with the Vector group. Meanwhile, AMPK overexpression showed significantly lower proliferation (the forth day: 0.53±0.03 vs. 0.64±0.05, P=0.021; the fifth day: 0.58±0.04 vs. 0.80±0.07, P=0.002) and weaken invasive ability ［(1.6±0.5)×105 vs. (3.4±0.3)×105, P=0.004］ of A549 cells. ConclusionThe lentiviral AMPK expression vector and its A549 cell line is successfully constructed. AMPK overexpression inhibits the proliferation and invasive ability of A549 cells.

Key words: Carcinoma, nonsmallcell lung, Lentivirus, Cell proliferation, AMPactivated protein kinase

Zhang Xiangmin, Liu Lianbin, Zeng Wen, Zhou Maohua, Ye Guilin, Ye Yongqiang, Wang Gang, Li Shaojin. Construction of overexpression lentiviral vector and its expression in lung cancer A549 cells of AMPactivated protein kinase[J]. Journal of International Oncology, 2017, 44(10): 721-726.

References

［1］ AlShahrabani F, Vallbhmer D, Angenendt S, et al. Surgical strategies in the therapy of nonsmall cell lung cancer［J］. World J Clin Oncol, 2014, 5(4): 595603. DOI: 10.5306/wjco.v5.i4.595. ［2］ Wang ZL, Fan ZQ, Jiang HD, et al. Selective Cox2 inhibitor celecoxib induces epithelialmesenchymal transition in human lung cancer cells via activating MEKERK signaling［J］. Carcinogenesis, 2013, 34(3): 638646. DOI: 10.1093/carcin/bgs367. ［3］ Brock SE, Rendon BE, Yaddanapudi K, et al. Negative regulation of AMPactivated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in nonsmall cell lung carcinomas［J］. J Biol Chem, 2012, 287(45): 3791737925. DOI: 10.1074/jbc.M112.378299. ［4］ Yim NH, Hwang YH, Liang C, et al. A platycosiderich fraction from the root of Platycodon grandiflorum enhances cell death in A549 human lung carcinoma cells via mainly AMPK/mTOR/AKT signalmediated autophagy induction［J］. J Ethnopharmacol, 2016, 194: 10601068. DOI: 10.1016/j.jep.2016.10.078. ［5］ Ramanan D, Tang MS, Bowcutt R, et al. Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus［J］. Immunity, 2014, 41(2): 311324. DOI: 10.1016/j.immuni.2014.06.015. ［6］ Reck M, Heigener DF, Mok T, et al. Management of nonsmallcell lung cancer: recent developments［J］. Lancet, 2013, 382(9893): 709719. DOI: 10.1016/S01406736(13)615020. ［7］ FernandezCuesta L, Mckay JD. Genomic architecture of lung cancers［J］. Curr Opin Oncol, 2016, 28(1): 5257. DOI: 10.1097/CCO.0000000000000251. ［8］ Pea CG, Castrillón DH. LKB1 as a tumor suppressor in uterine cancer: mouse models and translational studies［J］. Adv Exp Med Biol, 2017, 943(1): 211241. DOI: 10.1007/9783319431390_7. ［9］ Luo J, Hong Y, Lu Y, et al. AcetylCoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab［J］. Cancer Lett, 2017, 384: 3949. DOI: 10.1016/j.canlet.2016.09.020. ［10］ Chen J, Yuan J, Zhou L, et al. Regulation of different components from Ophiopogon japonicus on autophagy in human lung adenocarcinoma A549Cells through PI3K/Akt/mTOR signaling pathway［J］. Biomed Pharmacother, 2017, 87: 118126. DOI: 10.1016/j.biopha.2016.12.093. ［11］ Baek SH, Ko JH, Lee JH, et al. Ginkgolic acid inhibits invasion and migration and TGFβinduced EMT of lung cancer cells through PI3K/Akt/mTOR inactivation［J］. J Cell Physiol, 2017, 232(2): 346354. DOI: 10.1002/jcp.25426. ［12］ Kim N, Jeong S, Jing K, et al. Docosahexaenoic acid induces cell death in human nonsmall cell lung cancer cells by repressing mTOR via AMPK activation and PI3K/Akt inhibition［J］. Biomed Res Int, 2015, 2015: 239764. DOI: 10.1155/2015/239764. ［13］ Whang YM, Park SI, Trenary IA, et al. LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in nonsmallcell lung cancer (NSCLC) cells［J］. Oncogene, 2016, 35(7): 856866. DOI: 10.1038/onc.2015.140. ［14］ He K, Guo X, Liu Y, et al. TUFM downregulation induces epithelialmesenchymal transition and invasion in lung cancer cells via a mechanism involving AMPKGSK3β signaling［J］. Cell Mol Life Sci, 2016, 73(10): 21052121. DOI: 10.1007/s0001801521229. ［15］ Li Y, Cai X, Guan Y, et al. Adiponectin upregulates miR133a in cardiac hypertrophy through AMPK activation and reduced ERK1/2 phosphorylation［J］. PLoS One, 2016, 11(2): e0148482. DOI: 10.1371/journal.pone.0148482. ［16］ Law BY, Mok SW, Chan WK, et al. Hernandezine, a novel AMPK activator induces autophagic cell death in drugresistant cancers［J］. Oncotarget, 2016, 7(7): 80908104. DOI: 10.18632/oncotarget.6980. ［17］ Lee JS, Park SJ, Cho YS, et al. Role of AMPActivated protein kinase (AMPK) in smokinginduced lung inflammation and emphysema［J］. Tuberc Respir Dis (Seoul), 2015, 78(1): 817. DOI: 10.4046/trd.2015.78.1.8.

[1]	Ren Lu, Xie Xiaoli, Zhang Kun, Wang Lijuan. Effects and mechanisms of dihydroartemisinin combined with carfilzomib on the activity， proliferation， and apoptosis of multiple myeloma cells [J]. Journal of International Oncology, 2024, 51(3): 129-136.
[2]	Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong. Effects of Anhydroicaritin on the proliferation， migration and apoptosis of hepatocellular carcinoma cells [J]. Journal of International Oncology, 2023, 50(9): 513-519.
[3]	Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin. lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway [J]. Journal of International Oncology, 2023, 50(4): 202-207.
[4]	Lian Haiwei, Yang Shuorui, Liu Renzhong. Mechanism study on regulation of glioblastoma cell proliferation and apoptosis by sciadopitysin combined with CX-4945 through Notch1 pathway [J]. Journal of International Oncology, 2022, 49(6): 321-326.
[5]	Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing. MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2 [J]. Journal of International Oncology, 2022, 49(4): 193-198.
[6]	Laibijiang Wusiman, Cao Bowei, Zhang Wenbin, Gao Hua. Effects of exogenous AGR2 on the proliferation and invasion abilities of colon cancer cells [J]. Journal of International Oncology, 2022, 49(2): 73-78.
[7]	Zhang Yongli, Zhang Ruojia, Fan Huancai, Ge Luna, Wang Lin. TXNDC5-Prx2 axis regulates drug resistance of prostate cancer cells [J]. Journal of International Oncology, 2021, 48(8): 473-478.
[8]	Jiang Mengting, Wang Jiachun, Zong Jing. Effects of NFAT5 inhibition on proliferation, invasion, migration and apoptosis of lung adenocarcinoma cells [J]. Journal of International Oncology, 2021, 48(6): 321-327.
[9]	Yan Xingyu, Lian Zhenying, Diao Yutao, Liu Hongyan. BMXΔN mediates gefitinib resistance of lung cancer cells through ERK/MAPK signaling pathway [J]. Journal of International Oncology, 2021, 48(6): 328-334.
[10]	Ma Xiuzhen, Lu Yan, Zhao Bingbing, Qiu Hongcong, Xu Xun, Wei Min. Effects of total flavonoids from Baeckea frutescens on the migration, invasion and apoptosis of cervical cancer SiHa cells [J]. Journal of International Oncology, 2021, 48(4): 206-211.
[11]	Xiong Lin, Zhang Xiuyun, Zhang Xiaoyu, Li Yue, Xu Ximing. IWR-1-endo affects the migration and proliferation of hepatocarcinoma cells by inhibiting the Wnt pathway [J]. Journal of International Oncology, 2021, 48(12): 711-715.
[12]	Li Zhefeng, Li Jie, Zhao Xiaoting, Yue Wentao. GLDC regulates proliferation and apoptosis of ovarian cancer cells through PI3K/Akt/mTOR pathway [J]. Journal of International Oncology, 2021, 48(12): 716-722.
[13]	Zhong Yang, He Miao, Liu Zhi, Chen Jianyu, Zhang Guangnian, Qin Long, Li Ting, Li Jianshui. Effects of Ophiopogon D combined with cyclooxygenase-2 silencing on proliferation, migration and invasion of human pancreatic cancer BxPC-3 cells [J]. Journal of International Oncology, 2021, 48(10): 583-590.
[14]	Wei Mengyu, Ma Li. Research advances of Mfn2 in tumor [J]. Journal of International Oncology, 2021, 48(1): 45-47.
[15]	Cheng Hu, Liu Mingkui, Chen Tianping. Effects of lncRNA AFAP1-AS1 on proliferation and invasion of thyroid cancer cells and its mechanisms [J]. Journal of International Oncology, 2020, 47(6): 327-332.